A series of new water-soluble thalidomide prodrugs was prepared. All compou
nds were derivatized on the nitrogen of the glutarimide ring. Esters of nat
ural amino acids and succinic acid derivatives have been introduced by reac
tion with the hydroxymethyl thalidomide 2. Nicotinic acid derivatives were
prepared from halomethyl derivatives. Additionally, a methoxy methyl deriva
tive and a carboxymethyl derivative were prepared directly from thalidomide
. Most compounds showed a very large increase in water solubility compared
to thalidomide itself (0.012 mg/mL). The amorphous hydrochlorides of the N-
methylalanine ester 8, valine ester 9, and glycylglycine ester 10, respecti
vely, were the most soluble compounds showing solubility greater than 300 m
g/mL, which equals an increase greater than 15,000-fold. The lipophilicity
of the prodrugs has been determined by their HPLC capacity factors k '. The
stability of selected compounds was determined. The hydrolysis rates follo
w pseudo-first order kinetics. In order to assess the immunological activit
y, the prodrugs were tested using tumor necrosis factor-alpha and interleuk
in-2 inhibition assays. Selected compounds were additionally investigated o
n their abililty to inhibit the local Shwartzman reaction, an assay to dete
rmine the Vascular permeability. The prodrugs retained high effectiveness i
n the inhibition of TNF-alpha release. Our results indicated that the more
stable prodrugs exhibited higher activity in the immunological assays. Some
compounds showed higher activity than thalidomide itself, suggesting a hig
h affine binding to the pharmacophore. In conclusion, the prodrugs exhibite
d high water solubility and high activity and might therefore be used in th
erapeutic applications. (C) 2001 Elsevier Science Ltd. All rights reserved.